Hepatic ischemia/reperfusion (I/R) injury leads to oxidative stress and acute inflammatory responses that cause liver damage and have a considerable impact on the postoperative outcome. Much research has been performed to develop possible protective techniques. We aimed to investigate the efficacy of SPA0355, a synthetic thiourea analog, in an animal model of hepatic I/R injury. Male C57BL/6 mice underwent normothermic partial liver ischemia for 45 min followed by varying periods of reperfusion. The animals were divided into three groups: sham operated, I/R and SPA0355 pretreated. Pretreatment with SPA0355 protected against hepatic I/R injury, as indicated by the decreased levels of serum aminotransferase and reduced parenchymal necrosis and apoptosis. Liver synthetic function was also restored by SPA0355 as reflected by the prolonged prothrombin time. To gain insight into the mechanism involved in this protection, we measured the activity of nuclear factor-jB (NF-jB), which revealed that SPA0355 suppressed the nuclear translocation and DNA binding of NF-jB subunits. Concomitantly, the expression of NF-jB target genes such as IL-1b, IL-6, TNF-a and iNOS was significantly downregulated. Lastly, the liver antioxidant enzymes superoxide dismutase, catalase and glutathione were upregulated by SPA0355 treatment, which correlated with the reduction in serum malondialdehyde. Our results suggest that SPA0355 pretreatment prior to I/R injury could be an effective method to reduce liver damage.
INTRODUCTION
Ischemia/reperfusion (I/R) injury is a pathophysiologic process in which cellular damage is accentuated following oxygen delivery to the ischemic tissue. Liver I/R injury is a major cause of morbidity and mortality after resection surgery, liver transplantation, and hemorrhagic and septic shock. 1 Partial or total interruption of blood flow during liver surgery is called ischemia. During this period, the lack of tissue oxygen results in conversion of cellular metabolism from aerobic to anaerobic pathways and this metabolic change causes various hepatocellular dysfunctions. Upon revascularization, reoxygenation of the ischemic tissue generates various reactive oxygen species (ROS), which further contribute to profound hepatocellular injury-a phenomenon known as reperfusion injury. 2 Experimental evidence suggests that Kupffer cells are responsible for ROS generation in the early phase of reperfusion injury (up to 2 h after reperfusion). 3, 4 In addition to ROS, Kupffer cells produce and secrete proinflammatory cytokines such as tumor necrosis factor-a (TNF-a), interleukin (IL)-1 and IL-6. 5 These cytokines in turn attract and activate neutrophils during the late phase (6 h after reperfusion) of reperfusion injury. 6 Once neutrophils are recruited into the ischemic area, they further release ROS, cytokines, myeloperoxidase (MPO) and various other mediators, all of which amplify the tissue damage. 7, 8 Production of these proinflammatory cytokines/ chemokines is regulated by the transcription factor nuclear factor-kB (NF-kB), which is activated upon I/R injury. 1, 9 Additionally, NF-kB activation plays critical roles in the regenerative and antiapoptotic responses; [9] [10] [11] therefore, inhibition of NF-kB activation could contribute to preventing I/R injury. Indeed, several NF-kB suppressors, NF-kB decoy oligonucleotides and hepatocyte-specific ablation of IkB kinase (IKK) b have been proved to be effective in preventing I/R injury. [12] [13] [14] [15] Previously, we synthesized SPA0355, a thiourea analog, and reported its anti-inflammatory effect through suppression of the NF-kB pathway in an animal experimental model of arthritis. 16 In our latest publication, we showed that SPA0355 downregulated cytokine-induced pancreatic b-cell apoptosis by blocking the NF-kB and JAK-STAT pathways. 17 In the present study, we demonstrate that SPA0355 administration before liver I/R injury exerts hepatoprotective effects in a warm I/R liver injury model.
MATERIALS AND METHODS Animals
Pathogen-free 8-to 10-week-old C57BL/6 male mice (Orient, Seoul, Korea) were maintained on a standard laboratory chow diet and water ad libitum. All experimental protocols were approved by the Institutional Animal Care and Use Committee at Chonbuk National University.
Preparation of SPA0355
Preparation of SPA0355 (1-Methyl-3-[4-(2-phenoxazin-10-ylethoxy)-phenyl]thiourea) was performed as previously described. 16 
Model of partial hepatic I/R injury
Mice were anesthetized with ketamine (100 mgkg À1 ) and xylazine (10 mgkg À1 ) by intraperitoneal injection. A midline incision was performed and an atraumatic clip was placed across the portal vein, hepatic artery and bile duct just above the right branch. This interrupted blood flow to the left lateral and median lobes that represents approximately 70% of the total blood supply to the liver. The liver was kept moist with gauze soaked in saline, and body temperature was maintained at 37 1C with a warm blanket throughout ischemia. After 45 min of partial hepatic ischemia, the clip was removed to initiate reperfusion (Figure 1 ). Sham mice underwent the same operation without vascular occlusion. After the desired time period of reperfusion, the mice were killed by exsanguination under anesthesia and serum samples were collected. Left lateral and median lobes of the liver were collected and immediately fixed in 10% formalin or stored at À80 1C until further analysis.
Quantification of liver injury
Liver cell integrity was determined by assaying plasma levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activity (Asan Pharm, Seoul, Korea). Hepatocellular function was evaluated by measuring prothrombin time, which was quantified using a portable coagulometer (CoaguChek XS, Roche Diagnostics, Mannheim, Germany).
Protein extraction
Whole cell protein was extracted from liver tissue with T-PER tissue protein extraction reagent (Pierce Biotechnology, Rockford, IL, USA). For nuclear protein extraction, the liver samples were collected 60 min after reperfusion and immediately homogenized with a prechilled Dounce homogenizer (Wheaton Industries, Millville, NJ, USA). Nuclear protein was extracted with NE-PER nuclear and cytoplasmic extraction reagents (Pierce Biotechnology). Protein concentration was determined using the Bradford method.
Western blot analysis
Liver homogenates containing 30 mg of whole cell lysate protein or 10 mg of nuclear protein were separated by 10 or 12% SDS-PAGE and transferred to PVDF membranes. After blocking with 5% skim milk, the blot was probed with primary antibodies for p50, p65, IkBa, IKKa, IKKb, PCNA and b-actin (Santa Cruz Biotechnology, Santa Cruz, CA, USA), and cleaved caspase-3, Bcl-2, Bax, p-IKKa and p-IKKb (Cell Signaling Technology, Beverly, MA, USA). Horseradish peroxidase-conjugated anti-rabbit or anti-mouse IgG (Santa Cruz Biotechnology) was used as a secondary antibody.
Electrophoretic mobility shift assay
Nuclear extracts prepared from the liver tissues were incubated with a proteinase inhibitor cocktail (Thermo, San Diego, CA, USA) to inhibit endogenous protease activity. Oligonucleotide corresponding NF-kB site (5 0 -CCGGTTAACAGAGGGGGCTTTCCGAG-3 0 ) was synthesized and used as a probe for a gel retardation assay. The two complementary strands were then annealed and labeled with a-32 P-dCTP. Labeled oligonucleotide (10 000 counts per minute), 10 mg of nuclear extract, and binding buffer (10 mM Tris-HCl, pH 7.6, 500 mM KCl, 10 mM EDTA, 50% glycerol, 100 ng poly[dI Á dC], 1 mM dithiothreitol) were then incubated for 30 min at room temperature in a final volume of 20 ml. Next, the reaction mixtures were analyzed by electrophoresis on 4% polyacrylamide gels in a 0.5 Â Tris-borate buffer. The gels were dried and examined by autoradiography. The specificity of the DNAprotein interaction for NF-kB was confirmed by competition assays using a 50-fold excess of unlabeled oligonucleotide.
Histological study
Fixed liver tissues were embedded in paraffin. Tissue sections (5 mm) were stained with hematoxylin and eosin for light microscopy. TUNEL staining was performed using a commercial kit (R&D Systems, Minneapolis, MN, USA). Five to six random sections were investigated per slide to determine the percentage of necrotic cells.
RNA isolation and real-time RT-PCR
Total RNA was extracted from frozen liver tissue using Trizol reagent (Invitrogen, Carlsbad, CA, USA). First-strand cDNA was generated using the random hexamer primer provided in the first-strand cDNA synthesis kit (Applied Biosystems, Foster City, CA, USA). Specific primers for each gene (Table 1) were designed using primer express software (Applied Biosystems).
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as an invariant control. The realtime RT-PCR reaction mixture consisted of 10 ng reverse transcribed RNA, 200 nM forward and reverse primers, and 2 Â PCR master mixture in a final volume of 10 ml. The PCR reaction was carried out in 384-well plates using the ABI Prism 7900HT Sequence Detection System (Applied Biosystems).
Activities of superoxide dismutase, catalase, glutathione and malonidialdehyde
To analyze enzyme activities of superoxide dismutase (SOD), catalase (CAT) and glutathione (GSH), liver tissues were suspended in 10 mM phosphate buffer (pH 7.4), mixed with ice-cold 5% metaphosphoric acid solution and then homogenized. The homogenates were centrifuged at 3000 Â g for 10 min. The enzyme activities in the supernatant were determined using commercial assay kits (Enzo Life Sciences, Inc., Plymouth Meeting, PA, USA). Malondialdehyde (MDA) concentration in plasma was determined using a kit from Enzo Life Sciences, Inc. The method is based on the reaction of MDA with a chromogenic reagent, N-methyl-2-phenylindole. The absorbance of chromogenic product was measured at 586 nm.
MPO assay
Liver samples were homogenized and the pellet was resuspended in 1% hexadecyltrimethylammonium. After heating for 2 h at 60 1C, samples were centrifuged and the supernatant was incubated with 3,3 0 ,3,5 0 -tetramethylbenzidine followed by addition of H 2 O 2 . The change in optical density was measured at 650 nm.
Statistical analysis
Data were expressed as mean ± s.e.m. Statistical analyses were performed using one-way ANOVA for the comparison of data from different treatment groups. Differences with a P value o0.05 were considered statistically significant.
RESULTS
Intraperitoneal administration of SPA0355 attenuates liver injury and maintains liver function after I/R Liver injury was assessed by measuring serum levels of AST and ALT, and by determining prothrombin time. I/R injury induced significant increases in serum ALT and AST levels compared with sham-operated mice (Figure 2a) . However, pre-treatment with SPA0355 administered intraperitoneally three times before I/R injury augmented the elevation of serum ALT and AST levels in a dose-dependent manner. Specifically, 2.5 mgkg À1 SPA0355 reduced the AST level by 19.6% (Po0.05) and the ALT level by 21.3% (Po0.05), and the 5 mgkg À1 dose further reduced AST and ALT levels by 60.8% (Po0.01) and 59.2% (Po0.01), respectively. It is worth noting that no statistical difference was found between 5 and 10 mgkg À1 SPA0355, suggesting that 5 mgkg À1 of SPA0355 is sufficient to achieve full efficacy. In addition, prothrombin time was measured as a marker of liver synthetic function. I/R injury resulted in prolonged prothrombin time at 6 h after reperfusion, which was significantly decreased by pretreatment with 5 mgkg À1 SPA0355 (Figure 2b) .
Histologic changes following I/R were consistent with biochemical parameters of hepatic injury. Hematoxylin and eosin staining revealed extensive hepatocellular necrosis and sinusoidal congestion in mice subjected to 45 min of ischemia and 24 h of reperfusion compared with the sham group (Figure 2c) , with the area of necrosis being significantly different between the two groups. However, in mice that were pretreated with SPA0355, there were considerable areas of normal liver architecture and the area of necrosis was significantly lower compared with the I/R group.
Although the major cause of cell death during hepatic I/R injury is necrosis, apoptotic cell death is also observed during the injury process. 18 The number of apoptotic cells in I/Rinjured liver tissues was determined by TUNEL staining. As shown in Figure 2c , the number of TUNEL-positive apoptotic cells was significantly higher in the I/R-injured mice compared with that in the sham group. This observation correlated with increased protein levels of proapoptotic Bax and cleaved caspase-3 and decreased protein level of antiapoptotic Bcl-2 ( Figure 3 ). When mice were treated with SPA0355 before I/R injury, a significant reduction in apoptotic cells and concordant changes in apoptotic proteins were observed. Together, these results suggest that SPA0355 has protective effects against hepatic I/R injury.
SPA0355 decreases neutrophil infiltration
MPO, an enzyme that is predominantly stored in azurophilic neutrophil granules, was used to quantify neutrophil infiltration in the liver. After 24 h of reperfusion, MPO activity increased markedly in the I/R-injured mice compared with the sham group (Figure 4) . Consistent with the observed decrease in liver damage, the MPO activity of mice that were pretreated with 5 mgkg À1 SPA0355 was 48.5% of that in the vehicle group. These results suggest that suppression of neutrophil infiltration by SPA0355 may further contribute to protection against I/R injury.
SPA0355 inhibits the NF-kB signaling pathway
To determine whether SPA0355 exerted a liver protective effect through suppression of NF-kB activation, we measured protein levels of p65 and p50 subunits in nuclear extracts and DNA binding of NF-kB subunits prepared 1 h after reperfusion. SPA0355 prevents hepatic I/R injury U-J Bae et al I/R mice showed increases in nuclear p65 and p50 protein levels ( Figure 5a ) and binding activity of the p65 subunit to an NF-kB consensus sequence (Figure 5b ) compared with shamoperated mice. The DNA-bound p65 subunit of NF-kB was resolved by supershift (Figure 5b, lane 5) . In contrast, nuclear extracts prepared from mice that were pretreated with SPA0355 revealed markedly suppressed nuclear translocation and DNA binding of NF-kB. Consistently, I/R mice showed decreased levels of IkBa protein in the cytoplasm because of IkBa degradation, as compared with a similar fraction from sham mice, but IkBa degradation was markedly suppressed by SPA0355 pretreatment (Figure 5a ). Next, we tested the effect of SPA0355 on IKK activation, which is required for IkB degradation. SPA0355 had no effect on IKKa and IKKb protein levels, but suppressed I/R-induced IKK activity, as shown by decreased levels of phosphorylated forms of IKKa and IKKb (Figure 5c ). Together, these results suggested that SPA0355 inhibited the IkBa degradation by reducing IKK activities, thereby preventing subsequent NF-kB activation.
To further examine the effects of SPA0355 on NF-kB suppression, mRNA levels of NF-kB-dependent inflammatory mediators were measured by real-time RT-PCR. We observed a significant increase in IL-1b, IL-6, TNF-a and iNOS mRNA expression after hepatic I/R injury (Figure 5d ). However, prior injection with SPA0355 resulted in a dramatic decrease in expression of all of these mRNAs, indicating that the I/Rinduced increase in inflammatory mediator levels could be downregulated by SPA0355 treatment.
SPA0355 suppresses oxidative stress
The serum level of MDA, an indicator of oxidative damage, was also determined. As shown in Figure 6 , I/R significantly increased the MDA content in liver tissues compared with the sham group. Consistent with this finding, I/R caused Figure 2 Effect of SPA0355 on I/R-induced hepatocellular injury in mice. Mice were pretreated with the indicated concentrations of SPA0355 intraperitoneally three times before undergoing 45 min of hepatic ischemia. After 6 h reperfusion, serum levels of ALT and AST (a) and prothrombin time (b) were analyzed. (c) After 24 h reperfusion, liver tissues were fixed by 10% formalin, and liver necrosis and apoptosis were assessed by H&E and TUNEL staining, respectively. The area of necrosis was analyzed as described in the Materials and methods and TUNEL-positive apoptotic cells were counted and expressed as a percentage of all hepatocytes. Values are the mean±s.e.m. of three independent experiments (n ¼ 9 mice per group). **Po0.01 vs sham-operated mice; # Po0.05, ## Po0.01 vs I/R mice. H&E, hematoxylin and eosin; SPA5, 5 mgkg À1 SPA0355; VEH, vehicle.
significant suppression of the hepatic antioxidant defense, as observed by a decrease in the glutathione level and in SOD and CAT enzyme activities. Pretreatment with SPA0355 reversed these changes caused by I/R; the serum level of MDA was significantly lower and hepatic levels of glutathione, SOD and CAT were significantly higher in the SPA0355 group than in the I/R group. DISCUSSION I/R injury is, at least in part, a result of the inflammatory response, and NF-kB activation is central to the acute inflammatory response in I/R-injured liver tissue. 1, 9 In this respect, the use of NF-kB inhibitors to limit hepatic I/R injury has attracted attention. In this study, we tested whether SPA0355, which is known to have a NF-kB suppressive effect, would protect against hepatic I/R injury. Indeed, SPA0355 pretreatment in a mouse model of partial hepatic I/R resulted in a significant improvement in the plasma biochemical parameters of hepatocellular injury and amelioration of histopathologic findings of tissue damage in the liver.
As a key regulator of inflammatory and cell survival responses, NF-kB participates in both the generation of proinflammatory mediators and the antiapoptotic pathway, and the balance between these determines the fate of I/Rinjured liver tissue. 19 These contradictory roles of NF-kB help to explain several conflicting reports that NF-kB inactivation either protects against hepatic I/R injury 12, 14, 20 or aggravates such injury [21] [22] [23] although the underlying reasons for the conflicting activities are not entirely clear. Because NF-kB is differentially activated according to several environmental factors such as warm or cold I/R, partial or total I/R, species and genetic background of the animal, and duration and intensity of I/R, NF-kB activation should not be thought of as an event that aggravates or protects the liver, but rather is responsible for maintaining liver homeostasis during I/R injury. 9, 23 In our experimental conditions, tissue levels of proinflammatory mediators were markedly suppressed and the number of TUNEL-positive apoptotic hepatocytes was significantly reduced by SPA0355 treatment, suggesting that NF-kB suppression by SPA0355 shifted the balance toward suppression of the inflammatory response.
Reperfusion of the ischemic liver activates Kupffer cells, leading to the generation of ROS and expression of proinflammatory cytokines such as TNF-a and IL-b. 5 These cytokines upregulate the expression of adhesion molecules and recruit neutrophils into the liver, which leads to further production of ROS. 6 Previous studies have clearly demonstrated that ROS generation by either Kupffer cells or infiltrated neutrophils is responsible for tissue injury after reperfusion. 8 Accordingly, transgenic mice that overexpress SOD and CAT are protected against hepatic I/R injury. 24, 25 Similarly, intravenous administration of GSH also protects hepatocytes from I/R injury and improves animal survival. 26 In our study, hepatic I/R injury resulted in a significant increase in tissue MPO activity (an index of neutrophil infiltration), a decrease in tissue levels of SOD, CAT and GSH (indices of antioxidant capacities), and an increase in the plasma level of MDA (an index of lipid peroxidation). However, SPA0355 treatment dramatically reversed these changes, indicating that SPA0355 protected hepatocytes by reducing the oxidative stress caused by I/R injury.
Although necrosis is the major pathologic event during I/R injury, apoptotic cell death is also induced after hepatic I/R injury. Infiltrated neutrophils are known to mediate both apoptotic cell death and inflammation; 2 in fact, several pharmacologic or genetic interventions that suppress neutrophil infiltration have been shown to ameliorate both inflammation and apoptotic cell death after hepatic I/R injury. [27] [28] [29] [30] Under our experimental conditions, SPA0355 effectively reduced apoptotic damage as evidenced by a significant reduction in the number of TUNEL-positive apoptotic cells and decreased expression of apoptosis-related genes. As discussed earlier, SPA0355 suppressed neutrophil recruitment into the ischemic liver tissue, which might account for the reduction in apoptotic death of hepatocytes. In summary, we provide evidence that SPA0355 protects against I/R-induced liver damage. The mechanism of action of SPA0355 involves attenuation of NF-kB activation and the subsequent expression of proinflammatory mediators and suppression of oxidative stress, neutrophil infiltration and apoptosis. In both this and our previous studies, SPA0355 was well tolerated at the administered dose with no evidence of drug toxicity. 16, 17 Therefore, SPA0355 can be considered as a therapeutic option to prevent liver damage after medical or surgical conditions that interrupt blood flow to liver tissue. 
